Exome Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.55M	Buy	172,883 +112,283	+185%	+$1.01M	1.15%	33
2025 Q1	$455K	Buy	+60,600	New	+$455K	0.4%	45
2024 Q4	–	Sell	-196,500	Closed	-$1.49M	–	65
2024 Q3	$1.49M	Buy	+196,500	New	+$1.49M	1.01%	44